Centene is trading 4.1% down at $61.94 amid a broader healthcare-sector sell-off as investors assess insurance-coverage and ACA-subsidy risks.
- Centene’s Health Net exit from California and Oregon’s commercial group market remains an overhang but does not affect Marketplace, Medicaid, or Medicare businesses.
- No major Centene earnings or capital-markets event was scheduled for September 9, 2026.